Literature DB >> 24535241

Distribution of oral mucosal bacteria with mecA in patients undergoing hematopoietic cell transplantation.

Takayuki Ebinuma1, Yoshihiko Soga, Takamaro Sato, Kazuyuki Matsunaga, Chieko Kudo, Hiroshi Maeda, Yoshinobu Maeda, Mitsune Tanimoto, Shogo Takashiba.   

Abstract

PURPOSE: We recently reported frequent detection of antibiotic-resistant bacteria on the oral mucosa during the period of hematopoietic cell transplantation (HCT) and suggested an association between oral mucositis and antibiotic-resistant bacterial infection. Methicillin-resistant Staphylococcus spp. were frequently detected, and the oral cavity may be a reservoir of the gene mediating methicillin resistance, mecA. Here, we examined the frequency of mecA carriers in patients undergoing HCT.
METHODS: Fifty-nine patients (male (M) = 37, female (F) = 22, 47.3 ± 11.0 years) receiving HCT were enrolled in this study. Buccal swab samples were obtained four times from day -7 to day +20 (once/week), and mecA was detected by PCR. Fifty-two subjects without systemic disease, who completed dental treatment, especially periodontal treatment (M = 21, F = 31, 55.4 ± 14.2 years), were also enrolled as controls and checked for mecA on the oral mucosa.
RESULTS: Seventy-six percent (45/59) of the HCT patients carried mecA at least once in the study period (days -7 to +20), while no control subjects had mecA. The frequency of mecA carriers was 19.2 % from days -7 to -1, while it was significantly increased on days +7 to +13 and +14 to +20, with frequencies of 60.9 and 63.2 %, respectively (P < 0.01, ANOVA).
CONCLUSIONS: mecA was detected in oral mucosa of patients undergoing HCT. The high detection frequency of staphylococci resistant to penicillin and beta-lactams in our recent report was supported.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24535241     DOI: 10.1007/s00520-014-2151-1

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  14 in total

1.  2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Authors:  Walter T Hughes; Donald Armstrong; Gerald P Bodey; Eric J Bow; Arthur E Brown; Thierry Calandra; Ronald Feld; Philip A Pizzo; Kenneth V I Rolston; Jerry L Shenep; Lowell S Young
Journal:  Clin Infect Dis       Date:  2002-02-13       Impact factor: 9.079

2.  In-vivo transfer of mecA DNA to Staphylococcus aureus [corrected].

Authors:  C L Wielders; M R Vriens; S Brisse; L A de Graaf-Miltenburg; A Troelstra; A Fleer; F J Schmitz; J Verhoef; A C Fluit
Journal:  Lancet       Date:  2001-05-26       Impact factor: 79.321

Review 3.  Success through diversity - how Staphylococcus epidermidis establishes as a nosocomial pathogen.

Authors:  Sonja M K Schoenfelder; Claudia Lange; Martin Eckart; Susanne Hennig; Svitlana Kozytska; Wilma Ziebuhr
Journal:  Int J Med Microbiol       Date:  2010-05-06       Impact factor: 3.473

4.  Patient reports of complications of bone marrow transplantation.

Authors:  L A Bellm; J B Epstein; A Rose-Ped; P Martin; H J Fuchs
Journal:  Support Care Cancer       Date:  2000-01       Impact factor: 3.603

5.  Molecular cloning and nucleotide sequence determination of the regulator region of mecA gene in methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  K Hiramatsu; K Asada; E Suzuki; K Okonogi; T Yokota
Journal:  FEBS Lett       Date:  1992-02-24       Impact factor: 4.124

6.  Bacterial substitution of coagulase-negative staphylococci for streptococci on the oral mucosa after hematopoietic cell transplantation.

Authors:  Yoshihiko Soga; Yoshinobu Maeda; Fumihiko Ishimaru; Mitsune Tanimoto; Hiroshi Maeda; Fusanori Nishimura; Shogo Takashiba
Journal:  Support Care Cancer       Date:  2010-06-10       Impact factor: 3.603

7.  Antibiotic sensitivity of bacteria on the oral mucosa after hematopoietic cell transplantation.

Authors:  Yoshihiko Soga; Yoshinobu Maeda; Mitsune Tanimoto; Takayuki Ebinuma; Hiroshi Maeda; Shogo Takashiba
Journal:  Support Care Cancer       Date:  2012-09-25       Impact factor: 3.603

8.  Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation.

Authors:  S T Sonis; G Oster; H Fuchs; L Bellm; W Z Bradford; J Edelsberg; V Hayden; J Eilers; J B Epstein; F G LeVeque; C Miller; D E Peterson; M M Schubert; F K Spijkervet; M Horowitz
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

9.  Quantitative real-time PCR using TaqMan and SYBR Green for Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, tetQ gene and total bacteria.

Authors:  Hiroshi Maeda; Chiyo Fujimoto; Yasuhiro Haruki; Takemasa Maeda; Susumu Kokeguchi; Millan Petelin; Hideo Arai; Ichiro Tanimoto; Fusanori Nishimura; Shogo Takashiba
Journal:  FEMS Immunol Med Microbiol       Date:  2003-10-24

10.  Appearance of multidrug-resistant opportunistic bacteria on the gingiva during leukemia treatment.

Authors:  Yoshihiko Soga; Takashi Saito; Fusanori Nishimura; Fumihiko Ishimaru; Junji Mineshiba; Fumi Mineshiba; Hirokazu Takaya; Hideaki Sato; Chieko Kudo; Susumu Kokeguchi; Nobuharu Fujii; Mitsune Tanimoto; Shogo Takashiba
Journal:  J Periodontol       Date:  2008-01       Impact factor: 6.993

View more
  1 in total

1.  Dental status does not predict infection during stem cell transplantation: a single-center survey.

Authors:  A Guenther; E Losch; M Schiessl; A Schrauder; A Humpe; R Repp; T Nitsche; J Wiltfang; M Gramatzki
Journal:  Bone Marrow Transplant       Date:  2017-05-08       Impact factor: 5.483

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.